Sam Haidar

1.8k citations
12 papers · 1.4k · 1 hit paper · h-index 12

Impact in

  • Genetics top 2%
    • Glioma Diagnosis and Treatment
  • Neurology top 5%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Neurofibromatosis and Schwannoma Cases

Papers in

Sam Haidar

12 papers receiving 1.4k citations

Sam Haidar's Hit Papers

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study 2015 · 494 citations
4940+3+7Years since publication100200300400

Peers

Sam Haidar
Comparison fields: 5 of 74
  • Genetics 526
  • Neurology 156
  • Immunology 392
  • Cancer Research 256
  • Neurology 199
Replace Griffith Harsh with:
Griffith Harsh United States
Kristin D. Alfaro-Munoz United States
Jorge L. Samanamud United States
Pia Susann Zeiner Germany
Jacob Ruzevick United States
Alexander B. Kaplan United States
Christina Jackson United States
John F. de Groot United States
Márcia Regina Machein Germany
Lihong Long United States
Sam Haidar relative to Griffith Harsh United States Griffith Harsh's profile →
Citations per field
00.5×2×3.1×
Griffith Harsh · 1×
Citations per year

Countries citing papers authored by Sam Haidar

Since Specialization
Citations

This map shows the geographic impact of Sam Haidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Haidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Haidar more than expected).

Fields of papers citing papers by Sam Haidar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Haidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Haidar. The network helps show where Sam Haidar may publish in the future.

Co-authors

The 25 scholars most cited alongside Sam Haidar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sam Haidar Line = papers co-authored together Sam Haidar links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Hit paper breakdown →
2015494
2 2014245
3 2014228
4 2019130
5 201488
6 201282
7 201448
8 201543
9 201436
10 201324
11 201214
12
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
201414

About Sam Haidar

Sam Haidar is a scholar working on Genetics, Cancer Research, Modeling and Simulation, Biophysics and Epidemiology, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (2 papers), Meningioma and schwannoma management (2 papers), Single-cell and spatial transcriptomics (1 paper), Cancer Cells and Metastasis (1 paper), RNA regulation and disease (1 paper), Caveolin-1 and cellular processes (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Genetics (526 citations), Neurology (156 citations), Immunology (392 citations), Cancer Research (256 citations) and Neurology (199 citations). Sam Haidar has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Keith Lloyd Ligon, Patrick Yung Wen, Antonio M. P. Omuro, Brian L. West, Joanna J. Phillips, Howard Colman, Annette M. Molinaro, Adhirai Marimuthu, Cécile L. Maire and Nicholas Arthur Butowski. Their work appears in journals such as Neuro-Oncology, Stem Cells, Cancer Discovery, Oncotarget and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact